Skip to main content
SpringerLink
Log in

Wirkungsspektrum der Kalziumantagonisten bei koronarer Herzerkrankung

  • Conference paper
Book cover Therapie und Prävention mit Kalziumantagonisten

  • 14 Accesses

Zusammenfassung

Kalziumantagonisten stellen eine inhomogene Substanzgruppe dar, die man nach physiologischen, physikalischen oder chemischen Gesichtspunkten in verschiedene Untergruppen aufteilen kann. Bei Betrachtung der chemischen Strukturformeln lassen sich N-Heterozyklen und aliphatische Amine unterscheiden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arce-Gömez E, Aspey Rosas J, Alcocer-Diaz Barreiro L (1981) Efficacy of diltiazem hydrochlo-ride in the treatment of chronic angina patients. Curr Ther Res 30: 386

    Google Scholar 

  • Biagini A, Mazzei MG, Carpeggiani C, Testa R, Antonelli R, Michelassi C, L’Abbate A, Maseri A (1982) Vasospastic ischemic mechanism of frequent asymptomatic transient ST-T changes during continuous electrocardiographic monitoring in selected unstable angina patients. Am Heart J 130: 13

    Article  Google Scholar 

  • Dawson JR, Whitaker NHG, Sutton GC (1981) Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine. Br Heart J 46: 508

    CAS  Google Scholar 

  • Eichelbaum M, Somogyi A (1981) Pharmacokinetics and Bioviability of Verapamil during chronic oral dosing. Naunyn Schmiedebergs Arch Pharmacol, Suppl 73: 316

    Google Scholar 

  • Eichstädt H, Gutmann M, Schmutzler H, Felix R (1983) Nachweis verbesserter Mikroperfusion unter intravenöser und oraler Gabe des Calciumantagonisten Gallopamil. Z Kardiol 72: 24

    Google Scholar 

  • Fleckenstein A, Fleckenstein G, Späh F, Byon YK (1983) Gallopamil (D 600) — ein Kalziumanta-gonist von hoher Wirkungsstärke und Spezifität. Effekt auf Myokard und Schrittmacher. In: Kaltenbach M, Hopf R (Hrsg) Gallopamil — Pharmakologisches und klinisches Wirkungsprofil eines Kalziumantagonisten. Springer, Berlin, Heidelberg, New York, Tokyo, S 1

    Google Scholar 

  • Hopf R, Becker H-J, Kober G, Dowinsky S, Kaltenbach M (1982) Therapie der Angina pectoris mit Calcium-Antagonisten. Herz 7: 221

    PubMed  CAS  Google Scholar 

  • Johnson SM, Mauritson DR, Colbett JR, Woodward W, Willerson JT, Hillis LD (1981) Doubleblind randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. Am J Med 71: 443

    Article  PubMed  CAS  Google Scholar 

  • Mannhold R, Rodenkirchen R (1981) Pharmakologische Differenzierung von Calcium-Antagonisten. Pharmazie heute 104: 3, 139

    Google Scholar 

  • Nayler WG, Poole-Wilson Ph (1981) Calcium-antagonists: Definition and mechanisms of action. Basic Res Cardiol 76: 1

    Article  PubMed  CAS  Google Scholar 

  • Parodi O, Simonetti I, L’Abbate A, Maseri A (1982) Verapamil versus propranolol for angina at rest. Am J Cardiol 50: 923

    Article  PubMed  CAS  Google Scholar 

  • Raftos J (1980) Verapamil in the long-term treatment of angina pectoris. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy. Excerpta Medica, Amsterdam Oxford Princeton, p 167

    Google Scholar 

  • Schnellbacher K, Hirsch F, Roskamm H (1983) Exercise hemodynamics in angina pectoris patients after intravenous application of diltiazem. In: Fleckenstein A, Hashimoto K, Herrmann M, Schwartz A, Seipel L (eds) New calcium antagonists, recent developments and prospects. Fischer, Stuttgart, New York, S 175

    Google Scholar 

  • Subramanian VB, Bowles MJ, Khurmi NS, Davies AB, Raftery EB (1982) Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina. Am J Cardiol 50: 696

    Article  PubMed  CAS  Google Scholar 

  • Waters DD, Szlachcic J, Bourassa MG, Scholl JM, Théroux P (1982) Exercise testing in patients with variant angina: Results, correlation with clinical and angiographic features and prognostic significance. Circulation 65: 267

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Rudolf Virchow — Standort Charlottenburg — Freie Universität Berlin, Spandauer Damm 130, 1000, Berlin 19, Deutschland

    Prof. Dr. H. Eichstädt

Authors
  1. Prof. Dr. H. Eichstädt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

F. Bender A. Fleckenstein

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Eichstädt, H. (1988). Wirkungsspektrum der Kalziumantagonisten bei koronarer Herzerkrankung. In: Bender, F., Fleckenstein, A. (eds) Therapie und Prävention mit Kalziumantagonisten. Steinkopff. https://doi.org/10.1007/978-3-642-85362-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85362-3_5

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85363-0

  • Online ISBN: 978-3-642-85362-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation